Quick verdict
Henry Meds is the better pick for most patients on overall scoring. Henry built the cash-pay compounded GLP-1 category and still runs the cleanest version of it. Flat monthly pricing, no labs theater, true month-to-month. Pivoted hard after the FDA shortage delisting and now leans on personalization-claim 503A pharmacies.
That said, Eden wins on specific dimensions. Eden is the highest-volume compounded-only brand outside Henry. Slick funnel, low intro pricing, lots of upsell. Quality of clinical experience is thinner than Henry or Ivim and cancellation is the most common complaint thread.
Side-by-side
| Henry Meds | Eden | |
|---|---|---|
| Starts from | $297/mo (incl. medication) | $179/mo (incl. medication) |
| Lock-in | Month-to-month | 3-month minimum |
| Time to prescription | 2 days | 2 days |
| Consultation type | Asynchronous | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Henry Meds | Eden | |
|---|---|---|
| Pricing transparency | 8/10 | 7/10 |
| Cancellation terms | 9/10 | 5/10 |
| Onboarding experience | 8/10 | 8/10 |
| Medication options | 6/10 | 5/10 |
| Member outcomes | 7/10 | 6/10 |
When to choose Henry Meds
Buyers who want predictable flat-rate compounded semaglutide with no commitments and minimal friction.
When to choose Eden
Price-led buyers willing to navigate a heavier upsell flow for an aggressive intro price.
FAQ
Is Henry Meds cheaper than Eden?
Can I switch from Henry Meds to Eden mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →